What SYNLAB España does

SYNLAB España is the Spanish-market operation of SYNLAB International GmbH, a Munich-headquartered medical diagnostics provider operating in more than 20 countries across four continents with a network of over 300 laboratories and more than 1,800 blood collection points. The company delivers clinical diagnostics and anatomical pathology services spanning over 5,000 routine and specialty tests, including advanced genetic testing for hereditary cancer risk (BRCA1, BRCA2, HOXB13 and DNA repair gene variants) and population screening programs such as sickle cell disease testing. Group-level scale reached EUR 2.54 BN in revenue in 2025, supported by more than 23,000 employees including over 2,000 medical experts and international specialists, processing approximately 600 million laboratory tests annually.

The underlying technology platform is centered on physical laboratory infrastructure, sample logistics, and validated diagnostic assays rather than software-defined products. Supporting digital infrastructure includes a Google Maps-integrated lab locator tool, a multi-audience Value of Diagnostics content platform, and customer relationship channels spanning the corporate website, LinkedIn, Vimeo, and a medical newsletter. The company holds no disclosed AI/ML capabilities, patents, or proprietary models in the available data; technical differentiation is driven by domain specialization across thousands of test types and the depth of medical expertise.

SYNLAB operates a hybrid go-to-market combining direct-to-consumer patient access at physical collection points with B2B referral relationships to healthcare providers (doctors, hospitals, clinics) and B2B organizational contracts for corporate wellness and occupational health. Revenue is generated primarily through per-test and recurring diagnostic service contracts under a subscription/recurring model, with pricing varying by test type and market. Customer segmentation is horizontal across three personas (Patients and Individuals, Healthcare Providers, and Organisations), and no key account concentration is disclosed, implying a distributed, high-volume revenue base.

Name

SYNLAB España

Legal name

SYNLAB International GmbH

Website

https://synlab.es

Company type

Public

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

SYNLAB España is the Spanish unit of Munich-based SYNLAB International GmbH, providing clinical diagnostics and anatomical pathology through routine, specialty, and genetic testing. It serves patients, healthcare providers, and organisations across a network spanning 20+ countries, 300+ laboratories, and 1,800+ blood collection points.

Ownership category

akta.pro rank

Product category

Medical Diagnostics / Clinical Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

akta.pro secondary industries

Reference & Esoteric Testing Laboratories (HLAFAMAJ), Clinical Research & Trial Central Laboratories (HLAFAMAL), Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)

Keywords

• Clinical laboratory diagnostics
• Medical diagnostic testing
• Anatomical pathology services
• Genetic testing screening
• Blood collection services

Headquarters

HQ city

Esplugas De Llobregat

HQ country

Spain

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Laboratory Diagnostic Services: SYNLAB generates revenue through medical laboratory diagnostic services including routine testing, specialty testing, genetic testing, and related healthcare diagnostic services. The company processes approximately 600 million laboratory tests per year across its global network.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

SYNLAB España delivers clinical laboratory diagnostic testing and anatomical pathology services through a network of laboratories and blood collection points. It offers over 5,000 routine and specialty assays supporting prevention, diagnosis, treatment monitoring, and post-treatment follow-up, complemented by genetic and molecular diagnostics for precision medicine applications.

Product overview

SYNLAB operates as a unified medical laboratory diagnostics platform offering over 5,000 routine and specialty testing services across a network of 300+ laboratories and 1,800+ blood collection points in 20+ countries. The portfolio centers on core laboratory testing services (routine and specialty diagnostics), complemented by specialized genetic testing modules for precision medicine applications. Supporting infrastructure includes a laboratory locator tool, blood collection services network, and educational resources platform. The company processes approximately 600 million laboratory tests annually, serving patients, healthcare providers, and organisations with diagnostics that inform over 65% of clinical decision-making.

Differentiator

Problem solved

Functional benefit

Products and services

• Routine Laboratory Testing Services Core diagnostic testing services including standard blood tests, tissue analysis, and routine medical examinations performed across SYNLAB's network of over 300 laboratories, supporting prevention, diagnosis, treatment monitoring, and post-treatment follow-up for patients and healthcare providers.
• Specialty Laboratory Testing Services Advanced diagnostic testing services covering specialized areas including genetic testing, molecular diagnostics, and complex pathology analysis for healthcare providers and patients requiring higher-complexity clinical decisions.
• Genetic Testing and Screening Precision medicine-oriented genetic testing services including BRCA1/BRCA2 testing, HOXB13 analysis, and DNA repair gene variant screening for cancer risk stratification, screening guidance, and patient management.
• Blood Collection and Sample Collection Services Sample collection network comprising more than 1,800 blood collection points and 300+ laboratories across 20+ countries, providing convenient sample collection for diagnostic testing for patients and healthcare providers.

Quantifiable outcome

• Over 65% of clinical decision-making is based on laboratory testing
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature1 record

Scale indicators7 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Medicover: Medicover is a healthcare diagnostics and services provider operating across Central and Eastern Europe, with a growing laboratory diagnostics network and integrated clinic model. Its footprint overlaps with SYNLAB's Romania, Poland, and CEE presence, competing for the same regional providers and patients.
• Sonic Healthcare: Sonic Healthcare is a global medical diagnostics provider operating laboratories, pathology services, and radiology across Australia, Europe, and the US. Its European footprint and specialty diagnostics portfolio (including genetic testing) place it in direct competition with SYNLAB for the same hospital, physician, and direct-pay customers.
• Cerba Healthcare: Cerba Healthcare is a French-headquartered clinical diagnostics and specialty testing provider with operations across Europe and beyond. It competes with SYNLAB in routine clinical chemistry, specialty reference testing, and clinical trial central laboratory services, sharing a similar physician-referral GTM model.
• Unilabs: Unilabs is one of SYNLAB's closest European clinical diagnostics competitors, operating a similar pan-European network of laboratories, collection points, and radiology services. Both compete head-to-head in routine and specialty testing across Iberia, France, Switzerland, and the Nordics, with overlapping customer bases of providers, patients, and corporate clients.

Broad incumbents

• Eurofins Scientific: Eurofins is a large European-based testing services group spanning clinical diagnostics alongside food, environmental, and pharmaceutical testing. It competes with SYNLAB in clinical/medical diagnostics across Europe but also serves a much broader industrial testing customer base that SYNLAB does not address.
• Quest Diagnostics: Quest Diagnostics is a US-headquartered clinical laboratory giant providing routine, anatomic pathology, and advanced diagnostics to providers, employers, and consumers. It represents the most established US-based reference lab model that SYNLAB's specialist pan-European platform competes with in multinational pharma/biotech accounts.
• Laboratory Corporation of America (Labcorp): Labcorp is one of the largest global clinical laboratory operators, offering routine and esoteric diagnostics, drug development services, and direct-to-consumer testing. While its core footprint is North America, its clinical trials and specialty divisions overlap with SYNLAB's reference laboratory and clinical research activities.
• ARUP Laboratories: ARUP is a US-based nonprofit reference laboratory specializing in esoteric and complex testing for hospital systems and clinical trials. It competes with SYNLAB's specialty/reference testing arm and central lab services for biopharma clients globally.

Others

• Synlab subsidiaries – Reference Labs and Central Labs competitors: Inotiv/Quintiles (IQVIA's central lab) and other central-lab CROs operate in the clinical trial central laboratory niche adjacent to SYNLAB. They do not directly compete in routine clinical diagnostics but overlap in pharma-sponsored testing, kit logistics, and bioanalytical services.

Regional players

• Helios (Fresenius) Hospital Laboratory Services: Fresenius/Helios operates large hospital laboratory networks primarily in Germany and other parts of Europe, providing in-house and outsourced hospital diagnostics. It is structurally adjacent to SYNLAB's hospital-referral-driven volume business, though its focus on integrated hospital systems represents more captive than open-market competition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/synlab-international
• Xx.com/SYNLAB_ES

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SYNLAB España